ÖÐÎÄ°æ | English
 

Ô­ÁÏÒ©

ÖмäÌå

¶¨ÖƺϳÉ

¶àëÄϵÁÐ

ºËÜÕËáϵÁÐ

  °¢ßßɳ°à
  °¢Èðƥ̹
  ±½»ÇËá±´ÍÐ˾͡
  ¸»ÂíËá±ÈË÷Âå¶û
  èÛéÚËáÂÈÃ×·Ò
  »·Á×õ£°·
  ÇâäåËá´ï·ÇÄÇÐÂ
  ¾öÄδï¡
  ÑÎËá¾öÄδï¡
  ´ïɳÌæÄá(ÎÞË®)
  ´ïɳÌæÄá(һˮ)
  µØÀ­ÂÞ˾
  ·Ç²¼Ë÷̹
  ¸»ÂíËá·ÇË÷ÂÞ¶¨
  ÑÎËáÒÀ·¥²¼À׶¨
  Üá´ïÌØÂÞ
  À­ß»Ì涡
  ÑÇÒ¶Ëá¸Æ
  ×óÐýÑÇÒ¶Ëá¸Æ
  ¼×°±µûßÊ
  ßäßò˹͡
  ÑÎËá°ÂÂåËû¶¨
  ÑÎËáÆÕÀ­¸ñÀ×
  ÆÕÀ­¸ñÀ×
  ÅÁÁ¢¹Ç»¯´¼
  Àû·¥É³°à
  Î÷Âå¶àÐÁ
  èÛéÚËáËûĪÎô·Ò
  ·üÁ¢¿µßò
  ·ü¸ñÁв¨ÌÇ
  ½µ¸ÆËØ
  È¥°±¼ÓѹËØ
  ÌØÀû¼ÓѹËØ
  ¶÷·òΤµØ
  °£Ìæ·Ç°ÍëÄ/ÒÀ·Æ°ÍÌØ
  ÒȸßѪÌÇËØ
  ¸êÄÇÈðÁÖ
  ¸êÉáÈðÁÖ
  º£É³ÈðÁÖ
  ÁÁ±ûÈðÁÖ
  ÃÀÀ­ÅµÌ¹¢ò
  °ÂÇúëÄ
  ÉáĪÈðÁÖ
  Éú³¤ÒÖËØ
  ÐØÏÙÎåëÄ
  ÐØÏÙËØ
  ÇúÆÕÈðÁÖ
  ²¼ÉáÈðÁÖ
  µÂÉáÈðÁÖ
  ·òÌæÈðÁÖ
  ÄÇ·¨ÈðÁÖ/ÝÁ·¨ÈðÁÖ
  °¢À­ÈðÁÖ/±û°±ÈðÁÖ
  ×é°±ÈðÁÖ
  ±È·¥Â«¶¨/ ±ÈÍ߶û¶¡
  ÄÎÎ÷Á¢ëÄ
  °¬ÈûÄÇëÄ
  ÆÕÀ¼ÁÖëÄ
  ÀûÀ­Â³ëÄ
  5,6-¶þÒÒ»ù-2,3-¶þÇâ-1H-Üá-2-°·ÑÎËáÑÎ(Üá´ïÌØÂÞÖмäÌå)
  4-(4-°±»ù±½»ù)Âðßø-3-ͪ (Àû·¥É³°àÖмäÌå)
  (S)-(+)-N-(2,3-ÒÒÑõ»ù±û»ù)ÁÚ±½¶þ¼×õ£ÑÇ°·(Àû·¥É³°àÖмäÌå)
  (1S)-4,5-¶þ¼×Ñõ»ù-1-[(¼×»ù°±»ù)¼×»ù]±½²¢»·¶¡ÍéÑÎËáÑÎ(ÒÁ·¥²¼À׶¨ÖмäÌå)
  3-(3-Âȱû»ù)-1,3-¶þÇâ-7,8-¶þ¼×Ñõ»ù-2H-3-±½²¢µªÔÓ»·¸ý¶þÏ©-2-ͪ (ÒÁ·¥²¼À׶¨ÖмäÌå)
  (2-¶¡»ù-5-Ïõ»ù-3-±½²¢ß»à«»ù)[4-[3-(¶þ¶¡»ù°±»ù)±ûÑõ»ù]±½»ù]-¼×ͪ(¾öÄδï¡ÖмäÌå)
  (5-°±»ù-2-¶¡»ù-3-±½²¢ß»à«»ù)[4-[3-(¶þ¶¡»ù°±»ù)±ûÑõ»ù]±½»ù]-¼×ͪ¶þ²ÝËáÑÎ(¾öÄδï¡ÖмäÌå)
  2-¶¡»ù-3-(4-¼×Ñõ»ù±½¼×õ£»ù)-5-Ïõ»ù±½²¢ß»à«(¾öÄδï¡ÖмäÌå)
  2-¶¡»ù-3-(4-ôÇ»ù±½¼×õ£»ù)-5-Ïõ»ù±½²¢ß»à«(¾öÄδï¡ÖмäÌå)
  N-(3-Âȱû»ù)¶þ¶¡»ù°· (¾öÄδï¡ÖмäÌå)
  4-[(4-Âȱ½»ù)-2-ßÁऻù¼×Ñõ»ù]-1-ßßà¤ôÈËáÒÒõ¥(±´ÍÐ˹͡ÖмäÌå)
  2-[(4-Âȱ½»ù)(4-ßßऻùÑõ»ù)¼×»ù]ßÁठ(±´ÍÐ˹͡ÖмäÌå)
  2-[(4-Âȱ½»ù)£¨4-ßßà¤Ñõ»ù£©¼×»ù]ßÁठ¶ÔÏõ»ù±½¼×ËáÑÎ(±´ÍÐ˹͡ÖмäÌå)
  6-ÒÒ»ù-5-·ú-4-ôÇ»ùà×à¤(·üÁ¢¿µßòÖмäÌå)
  4-ÂÈ-6-ÒÒ»ù-5-·úà×à¤(·üÁ¢¿µßòÖмäÌå)
  (2R,3S/2S,3R)-3-(4-ÂÈ-5-·ú-6-à×ऻù)-2-(2,4-¶þ·ú±½»ù)-1-(1H-1,2,4-Èýßò-1-»ù)-2-¶¡´¼ÑÎËáÑÎ(·üÁ¢¿µßòÖмäÌå)
  (2R,3S/2S,3R)-2-(2,4-¶þ·ú±½»ù)-3-(5-·ú-4-à×ऻù)-1-(1H-1,2,4-Èýßò-1-»ù)-2-¶¡´¼(ÏûÐý·üÁ¢¿µßò)
  4-[(2-ôÈ»ù±½»ù)¼×Ñõ»ù]±½ÒÒËá(°ÂÂåËû¶¨ÖмäÌå)
  6,11-¶þÇâ-11-Ñõ´ú-¶þ±½²¢[b£¬e]ÑõÔÓ»·¸ý¶þÏ©-2-ÒÒËá(ÒÁË÷¿ËËá)
  [3-(¶þ¼×»ù°±»ù)±û»ù]Èý±½»ù]çlä廯ÎïÇâäåËáÑÎ (°ÂÂåËû¶¨ÖмäÌå)
  N-[4-[4-(ßß़׻ù)ßÁà¤-2-Ñõ]-˳ʽ-2-¶¡Ï©-1-»ù]ÁÚ±½¶þ¼×õ£ÑÇ°·ÂíÀ´ËáÑÎ (À­ß»Ì涡ÖмäÌå)
  2-ÂÈ-4-(ßßà¤-1-»ù¼×»ù)ßÁलÝËáÑÎ(À­ß»Ì涡ÖмäÌå)
  (2-߻ૼ׻ùÑÇ»Çõ£»ù)ÒÒËá-(4-Ïõ»ù±½·Ó)õ¥(À­ß»Ì涡ÖмäÌå)
  5,6,7,8-ËÄÇâ-2-ÝÁ·Ó(ÀûÀ­ÝÁõ¥ÖмäÌå)
  2,3-¶þÇâ±½²¢ß»à«-5-ÒÒËá(´ï·ÇÄÇÐÂÖмäÌå)
  5-(2-äåÒÒ»ù)-2,3-¶þÇâ±½²¢ß»à«(´ï·ÇÄÇÐÂÖмäÌå)
  (S)-2,2-¶þ±½»ù-2-(1-¶Ô¼×±½»Çõ£»ùßÁ¿©-3-»ù)ÒÒëæ(´ï·ÇÄÇÐÁÖмäÌå)
  2,2-¶þ±½»ù-2-[(3S)-ßÁ¿©-3-»ù]ÒÒõ£°· L-¾ÆʯËáÑÎ(´ï·ÇÄÇÐÂÖмäÌå)
  2-(3-È©»ù-4-ôÇ»ù±½»ù)-4-¼×»ùàçßò-5-ôÈËáÒÒõ¥(·Ç²¼Ë÷̹ÖмäÌå)
  2-(3-Çè»ù-4-Ò춡Ñõ»ù±½»ù)-4-¼×»ùàçßò-5-ôÈËáÒÒõ¥(·Ç²¼Ë÷̹ÖмäÌå)
  2-°±»ù-2-[2-[2-ÂÈ-4-[[3-(ÜÐÑõ»ù)±½»ù]Áò]±½»ù]ÒÒ»ù]-1,3-±û¶þ´¼ÑÎËáÑÎ
  ßÅßá-7-ÅðËá
  2-(Âȼ׻ù)-3-(Èý·ú¼×»ù)ßÁà¤
  ÏãÊ÷ËØ
  Diphenyleneiodonium Sulfate
  4-äåàçßò-2-¼×ËáÒÒõ¥
  1-(2-Methylpyrimidin-5-yl)ethanamine
  3-Chloromethyl-1,2,4-oxadiazole
  5-Chloropyrazine-2-carbaldehyde
  2,3-Pyridinedicarboxylicacid,4-amino-,dimethylester
  Methyl 3-amino-5,6-dimethylpyrazine-2-carboxylate
  Ethyl 3-amino-4-methoxythieno[2,3-b]pyridine-2-carboxylate
  Ethyl 3-amino-5-nitrothieno[2,3-b]pyridine-2-carboxylate
  1-(5-Methylpyrimidin-2-yl)ethanol
  7-Chloro-5-methoxy-Thieno[3,2-b]pyridine
  2-Bromo-7-chloro-thieno[3,2-b]pyridine
  5-äå-2-ÜáÂú´¼
  5,7-Dichloro-pyrido[4,3-d]pyrimidin-4(3H)-one
  3-Bromo-5-methyl-1H-pyrazole
  ÂÞÃÀÎô²¼
  °¢ÈûÄÇƽ
  Â³À­Î÷ͪ
  Â³À­Î÷ͪ
  ÑÎËá³À­Î÷ͪ
  ²´É³¿µßò
  °®Î¬ÄªÅË
  ¾ÆʯËῨ°ÍÀ­Í¡
  ¼×»ÇËáÀ×ɳ¼ªÀ¼
  L-¦Á-°±»ùËáÐÁ¶þËá
  5-[(2R)-2-°±»ù±û»ù]-2,3-¶þÇâ-1-[3-(±½¼×õ£Ñõ»ù)±û»ù]-1H-ßÅßá-7-ëæ¾ÆʯËáÑÎ( Î÷Âå¶àÐÁÖмäÌå)
  2-[2-(2,2,2-Èý·úÒÒÑõ»ù)±½Ñõ»ù]ÒÒ»ù¼×»ÇËáõ¥
  1-»·±û»ù-2-(2-·ú±½»ù)ÒÒͪ
  5,6,7,7a-ËÄÇâàç·Ô²¢[3,2-c]ßÁà¤-2(4H)-ͪ¶Ô¼×±½»ÇËáÑÎ
  5,6,7,7a-ËÄÇâ-5-(Èý±½¼×»ù)àç·Ô²¢[3,2-c]ßÁà¤Íª
  4-(2-ôÇÒÒ»ù)Ñõ»¯ßÅßá
  2,3,4,6-ËÄ-O-Üлù-a-D-ÆÏÌÑÌÇ9
  ËÄÜлù·ü¸ñÁв¨ÌÇ
  4,5-¶þ¼×Ñõ»ù-1-Çè»ù±½²¢»·¶¡Íé(ÒÁ·¥²¼À׶¨ÖмäÌå)
  (S)-4[1-(4-Âȱ½»ù)-1-(2-ßÁऻù) ¼×Ñõ»ù]ßßà¤(±´ÍÐ˹͡ÖмäÌå)
  ÑÎËáÀ¼µØÂå¶û
  (S)-(2,2-¶þ¼×»ù-1,3-¶þÑõ»·ÎìÍé-4-»ù)¼×»ù 3-(4-ôÇ»ù±½»ù)±ûËáõ¥
  (S)-(+)-¼äÏõ»ù±½»ÇËáËõË®¸ÊÓÍõ¥
  N-(2-°±»ùÒÒ»ù)-4-Âðßø¼×õ£°·²ÝËáÑÎ
  ¼×°±µûßʶþÄÆÑÎ
  2,4,5,6-ËÄ°±»ùà×à¤ÁòËáÑÎ
  6-(äå¼×»ù)-2,4-µûशþ°·ÇâäåËáÑÎ
  2,3,4,6-ËÄÜлù-D-ßÁà«ÆÏÌÑÌÇ(·ü¸ñÁв¨ÌÇÖмäÌå)
  8-ÜÐÑõ»ù-5-(2-äåÒÒõ£»ù)-2-ôÇ»ùà­ßø (Üá´ïÌØÂÞÖмäÌå)
  (3AR,4S,7R,7AS)-rel-ÁùÇâ-4,7-¼×ÇÅ-1H-ÒìßÅßá-1,3(2H)-¶þͪ(³À­Î÷ͪÖмäÌå)
  (3R,4R)-3-(3,4-¶þ¼×»ù-4-ßßऻù)±½·Ó (°®Î¬ÄªÅËÖмäÌå)
  (alphaS,3R,4R)-4-(3-ôÇ»ù±½»ù)-3,4-¶þ¼×»ù-alpha-Üлù-1-ßßऱûËá¼×õ¥(°®Î¬ÄªÅËÖмäÌå)
  (R)-2-Üлù-3-[(3R,4R)-4-(3-ôÇ»ù±½»ù)-3,4-¶þ¼×»ùßßà¤-1-»ù]±ûËá(°®Î¬ÄªÅËÖмäÌå)
  ¶÷Ì濨Τ
  2-[(S)-(4-Âȱ½»ù)(4-ßßऻùÑõ»ù)¼×»ù]ßÁठ(2R,3R)-2,3-¶þôÇ»ù¶¡¶þËáÑÎ(±´ÍÐ˹͡ÖмäÌå)
  (5R-cis)-¼×±½-4-»ÇËá 5-(2,4-¶þ·ú±½»ù)-5-(1H-1,2,4-Èýµªßò-1-»ù)¼×»ùËÄÇâß»à«-3-»ù¼×»ùõ¥
  2-[(1S,2S)-1-ÒÒ»ù-2-ÜÐÑõ»ù±û»ù]-2,4-¶þÇâ-4-[4-[4-(4-ôÇ»ù±½»ù)-1-ßßົù]±½»ù]-3H-1,2,4-Èýµªßò-3-ͪ
  Æ¥¶àĪµÂ
  À×ÌæÇúÈû
  ÅàÃÀÇúÈû¶þÄÆ
  °ÂÃÀɳ̹õ¥
  ¶àË÷²è¼î
  ÑÎËá°¢ÄǸñÀ×
  °¢ÄǸñÀ×
  ÑÎËáÆÕÀ­¿ËË÷
  Trans-(+/-)-11-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole-1-one
  11-chloro-2,3-dihydro-2-methyl-1H-dibenz[2,3;6,7]oxepino[4,5-c]pyrrol-1-one
  (5-Chloro-2-phenoxyphenyl)acetic acid
  Trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one
  Cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one
  Mixture of Trans and Cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one
  5-Chloro-2-Methyl-2,3-Dihydro-Benzo-[2,3:6,7]-Oxepino-[4,5-C]-pyrrole-(2H)-One
  ´ï±È¼ÓȺõ¥¼×»ÇËáÑÎ
  ´ï±È¼ÓȺõ¥
  3-[(3-°±»ù-4-¼×»ù°±»ù±½¼×õ£)ßÁà¤-2-»ù°±»ù]±ûËáÒÒõ¥
  N-(4-Çè»ù±½»ù)¸Ê°±Ëá
  4-¼×°±»ù-3-Ïõ»ù±½¼×Ëá
  3-(ßÁà¤-2-»ù°±»ù)±ûËáÒÒõ¥
  2-(4-¼×Ñõ»ù-1,4-»·¼º¶þÏ©-1-»ù)-2-±û´¼
  5-(1,1-¶þ¼×»ù¸ý»ù)¼ä±½¶þ·Ó
  2-ôÇ»ùà­ßø-4-ôÈËá
  ÑǼ׻ù¶þÁ×ËáËÄÒì±ûõ¥
  ÒѶþËáçúçêõ£ÑÇ°·¶þõ¥(SIDEA)
  ÈýÒÒ¶þ´¼¶þ¶Ô¼×±½»ÇËáõ¥
  5-[(2S)-2-°±»ù±û»ù]-2,3-¶þÇâ-1-[3-(±½¼×õ£Ñõ»ù)±û»ù]-1H-ßÅßá-7-ëæ-D-(-)-¾ÆʯËáÑÎ
  5-[(2R,S)-2-AMINOPROPYL]-1-[3-(BENZOYLOXY)PROPYL]-2,3-DIHYDRO-1H-INDOLE-7-CARBONITRILE
  (R)-ËÄÂÈàç·Ô-3-´¼
  ethyl 4-(4-hydroxypiperidin-1-yl) butanoate
  (S)-(4-Âȱ½»ù)(ßÁà¤-2-»ù)¼×´¼
  ethyl 4-(4-bromoypiperidin-1-yl)butanoate
  1-±½²¢àç·Ô-3-ôÈËá
  ÒÀ¶Èɳ°à¶Ô¼×±½»ÇËáÑÎһˮºÏÎï
  ÒÀ¶Èɳ°àBASE
  ÒÀ¶Èɳ°àÖмäÌå1
  ÒÀ¶Èɳ°àÖмäÌå2
  ÒÀ¶Èɳ°àÖмäÌå3
  N-[3-·ú-4-[(¼×»ù°±»ù)ôÊ»ù]±½»ù]-2-¼×»ù-
  N-[3-·ú-4-[(¼×»ù°±»ù)ôÊ»ù]±½»ù]-2-¼×»ù-
  4-ÒìÁò´úÇèõ£»ù-2-(Èý·ú¼×»ù)±½¼×ëæ
  ¶÷Ôú³°·
  1-»·±û»ù-4-ÒìÁò´úÇèõ£»ùÝÁ
  THR-PHE-GLN-ALA-TYR-PRO-LEU-ARG-GLU-ALA
  esinurad
  (R)-3-°±»ù-1-¶¡´¼
  1533519-85-5
  °¢ÆÕ˹ÌØ
  °¢ÆÕ˹ÌØ
  4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5(4H)-thione
  ÑÎËá°¢¿¼Ìæ°·
  ÓÒÀ¼Ë÷À­ßò
  MK-4305
  ÍбÈ˾Ëû
  °Â±´µ¨Ëá
²úÆ·Ãû³Æ:(2-߻ૼ׻ùÑÇ»Çõ£»ù)ÒÒËá-(4-Ïõ»ù±½·Ó)õ¥(À­ß»Ì涡ÖмäÌå) 
Cas No.:123855-55-0 
¹æ¸ñ:99% 
·Ö×Óʽ:C13H11NO6S 
·Ö×ÓÁ¿:309.29 
½á¹¹Ê½: 
     
2011±±¾©ÏèÓîºãÌìÒ½Ò©¼¼ÊõÓÐÏÞ¹«Ë¾°æȨËùÓР |  ¾©ICP±¸09110018ºÅ  |  µØÖ·£º±±¾©Êк£µíÇøÓÀ¶¨Â·¼×4ºÅAÔº3ºÅÂ¥323ÊÒ
µç»°£º 010-88755821  |   ´«Õ棺 010-58043698  |   ÁªÏµÈË£ºÀî¾­Àí
ÓÊÏ䣺Contact@EagleSkyPharmatech.com  |  marketing@EagleSkyPharmatech.com ¼¼ÊõÖ§³Ö£º»ªÏÄ»¯¹¤Íø